Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons S.H. Binnenmars

Publicaties

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities

Fibroblast Growth Factor 23 and Risk of New Onset Heart Failure With Preserved or Reduced Ejection Fraction: The PREVEND Study

Interleukin 6 and Development of Heart Failure With Preserved Ejection Fraction in the General Population

Serum free sulfhydryl status associates with new-onset chronic kidney disease in the general population

Fibroblast Growth Factor 23 and Mortality in Patients With Type 2 Diabetes and Normal or Mildly Impaired Kidney Function

Impact of Moderate Sodium Restriction and Hydrochlorothiazide on Iodine Excretion in Diabetic Kidney Disease: Data from a Randomized Cross-Over Trial

Biomarkers of Renal Function: Towards Clinical Actionability

Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT)

Concordance of dietary sodium intake and concomitant phosphate load: Implications for sodium interventions

Effects of sodium restriction and hydrochlorothiazide on RAAS blockade efficacy in diabetic nephropathy: A randomised clinical trial